Massachusetts 2025-2026 Regular Session

Massachusetts House Bill H1287

Introduced
2/27/25  

Caption

Relative to the treatment of infantile cataracts

Summary

H1287 would require health insurance policies in Massachusetts that already cover infantile cataract surgery to also cover aphakic lenses used in treatment and rehabilitation. The bill specifies that this coverage must include prosthetic contact lenses or glasses when they are medically necessary as determined by the physician. It applies this requirement across multiple categories of coverage, including state employee plans, Medicaid, commercial insurers, Blue Cross Blue Shield, HMOs, and other health benefit plans governed by the cited chapters of the General Laws. The bill is narrowly focused on ensuring that children who undergo infantile cataract surgery can obtain the visual correction devices needed after surgery without facing separate coverage gaps. By adding identical language to several insurance statutes, it creates a uniform mandate across major Massachusetts health insurance frameworks and overrides any conflicting general or special law, rule, or regulation. In practical terms, it would expand mandated benefits for pediatric eye care and rehabilitation and could shift costs to insurers and, indirectly, premium payers or public programs.

Impact

The bill would amend Chapters 32A, 118E, 175, 176A, 176B, 176G, and 176I of the General Laws to require coverage of aphakic lenses whenever a policy covers infantile cataract surgery. This would create a new mandated benefit for prosthetic contact lenses or glasses deemed medically necessary by the physician, affecting both public and private health insurance plans covered by those chapters. It would likely increase insurer obligations for pediatric ophthalmic follow-up care and standardize coverage for a specific post-surgical treatment across the Commonwealth.

Sentiment

There is no recorded committee testimony or vote history in the provided materials, so formal sentiment cannot be measured from debate or roll call. The bill’s text suggests a supportive, patient-protection approach aimed at ensuring medically necessary follow-up care for infants with cataracts. The absence of opposition or amendments in the available record leaves the overall legislative sentiment unclear, though the measure appears designed to address a targeted coverage gap rather than a broad policy dispute.

Contention

The main potential point of contention is the creation of a new insurance mandate, which may raise concerns about added costs for insurers, public programs, and ultimately premiums. Another possible issue is the breadth of the mandate across multiple insurance chapters, since it applies uniformly to several plan types rather than being limited to a single market segment. Supporters would likely emphasize medical necessity and access to rehabilitation, while any critics would focus on cost, mandate expansion, or whether existing coverage already addresses some of these needs.

Companion Bills

MA H5225

Replaced by Study Order

Previously Filed As

MA H5225

Study Order

MA HB696

AN ACT relating to infantile seizure disorder.

MA H673

Improving student access to life saving treatments

MA H1290

Relative to dental insurance coverage of periodontal treatments

MA H2415

Relative to safer treatment

MA H1172

Relative to insurance coverage for new treatment

MA H1277

Relative to dual diagnosis treatment coverage

MA S771

Relative to dual diagnosis treatment coverage

MA S1148

Relative to the fair treatment of employees

MA S712

Relative to ensuring treatment for genetic craniofacial conditions

Similar Bills

MA H5225

Study Order

NJ AJR19

Designates May 7 of each year as "Cystinosis Awareness Day" in New Jersey.

FL H0733

Department of Health

KY HB696

AN ACT relating to infantile seizure disorder.

VA HJR499

Krabbe Disease Awareness Day; designating as February 28, 2025, and each succeeding year thereafter.

AL HJR202

Alabama Legislature

AL SJR57

Alabama Legislature

FL H0449

Optometry